FTX-6058 is a potent and orally active inhibitor of Embryonic Ectoderm Development (EED). FTX-6058 can induce HbF protein expression in cell and murine models. FTX-6058 can be used for the research of select hemoglobinopathies, including sickle cell disease and β-thalassemia.
性状
Solid
体外研究(In Vitro)
FTX-6058 inhibits PRC2 via binding to EED, which induces robust HbF protein expression in both cell and murine models. has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Powder -20°C 3 years;4°C 2 years
参考文献
[1]. Boerner LK. Virtual meeting delivers first time drug structures. April 12, 2021.[2]. Fulcrum Therapeutics Presents Published Structure of Investigational Small Molecule FTX-6058 at the American Chemical Society (ACS) Spring 2021 Virtual Conference.
溶解度数据
In Vitro: DMSO : 125 mg/mL (309.86 mM; Need ultrasonic)配制储备液
[1]. Boerner LK. Virtual meeting delivers first time drug structures. April 12, 2021.[2]. Fulcrum Therapeutics Presents Published Structure of Investigational Small Molecule FTX-6058 at the American Chemical Society (ACS) Spring 2021 Virtual Conference.